Search

RAMCE hosts regenerative medicine conference

Written by...

More than 300 medical professionals gathered in London on November 9 to enhance their knowledge of regenerative aesthetic treatments.

It was the second year for the Regenerative Aesthetic Medicine Conference and Exhibition (RAMCE), which took place in the Pullman Hotel, London. Chaired by Professor Maurizio Cavallini, Dr David Eccleston and Dr Yusra Al-Mukthar, the sessions taught practitioners how to optimise results with innovative treatments and expert techniques.

Speakers explored the differences between polynucleotides and exosomes, treating the intimate area, chemical peeling’s regenerative action, and shaping regenerative medicine for your patients. There were also engaging panel discussions on the value of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), using combination approaches and the role of dermal fillers, toxins and threads in the regenerative space.

New products were also launched with aesthetic practitioner Dr Xavier Goodarzian introducing the audience to the Liquid Laser. This incorporates Purasomes with chemical peeling and microneedling. Dr Goodarzian guided delegates through its application and showcased the results.

To conclude the day, Shannon Kilgariff, editor and event manager at Aesthetics, hosted an evening with Professor Cavallini to share more about how he became a polynucleotides pioneer. Reflecting on the day, Professor Cavallini said, “RAMCE 2024 was a fantastic day of learning and networking. We have already had excellent feedback from delegates, who valued the in-depth discussions and introduction of innovative new products and techniques. I look forward to working with the team to further advance this event in 2025.”

Aesthetic practitioner and president of the British College of Aesthetic Medicine (BCAM), Dr Catherine Fairris, said, “I’m here today because regenerative medicine is the future of medical aesthetics. We’re seeing a huge shift towards more natural and holistic approaches to treatments.”

Share this article: